Market size, growth to 2033 and clinical trials, side by side.
Germany is the bigger Cardiovascular Health Supplements market: $249 Mn against $177 Mn in 2023, about 1.4 times as large.
Germany grows faster: 3.9% a year, against 3.7%.
Clinical research: 9 active trials in the UK, 6 in Germany.
| Measure | ||
|---|---|---|
| Market size, 2023 | $177 Mn | $249 Mn |
| Market size, 2033 projected | $254 Mn | $365 Mn |
| Growth a year (CAGR) | 3.7% | 3.9% |
| Money added, 2023–2033 | $78 Mn | $116 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $2.54 | $2.98 |
| Active clinical trials | 9 | 6 |
| High blood pressure (ages 30–79) % of adults 30–79 (WHO) | 26.4 2019 | 29.7 2019 |
| Full report | UK report | Germany report |
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Germany is the bigger Cardiovascular Health Supplements market: $249 Mn against $177 Mn in 2023, about 1.4 times as large.
Germany grows faster: 3.9% a year, against 3.7%.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.